Influenza B BY PCR

Influenza B BY PCR is a molecular diagnostic test that detects Influenza B viral RNA in respiratory specimens using real-time reverse transcription PCR (RT‑PCR). It provides sensitive and specific identification of Influenza B infection, helping distinguish it from other respiratory pathogens and guiding timely clinical decisions on antiviral therapy and infection control. Samples can be collected at home across Dubai and the UAE by trained personnel and are analysed in UAE‑accredited laboratories for reliable, timely reporting.

• Influenza B virus RNA (RT‑PCR)
• Qualitative result: Detected / Not detected
• Cycle threshold (Ct) value
• Internal control / sample adequacy (e.g., RNase P)

• Acute onset of fever with cough, sore throat, or myalgia
• Severe respiratory symptoms or worsening shortness of breath
• Known exposure to a confirmed Influenza B case or outbreak
• High‑risk individuals (young children, elderly, pregnant, immunocompromised)
• Hospital admission or when confirmation affects treatment/isolation

• High sensitivity and specificity for Influenza B detection
• Enables early antiviral treatment and appropriate infection control
• Convenient home sample collection across Dubai and the UAE
• Analysis by UAE‑accredited laboratories for reliable results
• Rapid electronic reporting (typical turnaround 24–48 hours)

• Nasopharyngeal and/or throat swab collected by trained technician
• Best performed within 72 hours of symptom onset when possible
• No fasting or medication stoppage required prior to sampling
• Provide valid Emirates ID/passport and a local contact number for results